This inventor holds 29 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Rigel Pharmaceuticals, Incorporated, Syntex (u.s.a.) Inc., Roche Palo Alto LLC. Active years: 2001-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Fremont, CA (US) (2001 - 2013)
- Palo Alto, CA (US) (2009 - 2022)
Company Filing History:
24 out of 492 
4 out of 932 
1 out of 322 
Years Active: 2001-2022
Areas of Expertise:
Title: Innovations by Thomas Weitao Sun: Significant Contributions to Pharmaceutical Chemistry
Introduction
Thomas Weitao Sun, an accomplished inventor based in Fremont, CA, has made remarkable strides in the field of pharmaceutical chemistry. With a total of 29 patents to his name, his contributions are vital to advancing medicinal compounds and their therapeutic applications.
Latest Patents
Among his latest achievements, Sun has developed prodrugs of biologically active 2,4-pyrimidinediamine compounds. These prodrugs come with an array of benefits, as they include compositions comprising the prodrugs, salts, and hydrates, along with detailed methods for synthesizing these compounds. His work provides valuable insights into various applications of these medicinal compounds, highlighting their significance in modern pharmaceutical practices.
Career Highlights
Throughout his career, Thomas Weitao Sun has worked for prominent companies, including Rigel Pharmaceuticals, Incorporated, and Syntex (U.S.A.) Inc. His tenure in these organizations has substantially impacted the research and development of innovative drug solutions, solidifying his reputation in the industry.
Collaborations
Sun's innovation journey has been complemented by collaborations with skilled professionals, such as Rajinder Paul Singh and Somasekhar Bhamidipati. These partnerships have contributed to the growth and evolution of his groundbreaking inventions, further enhancing the potential of his pharmaceutical contributions.
Conclusion
Thomas Weitao Sun's impressive portfolio of patents and his dedicated career in pharmaceutical research underline his role as a significant innovator in the industry. His ongoing work with 2,4-pyrimidinediamine compounds exemplifies how his inventions can shape the future of medicine and provide solutions for various therapeutic needs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile